KDM4B expression is increased in both AML patients and in MLL-AF9-transduced cord blood CD34+ cells, indicating an involvement of KDM4B in AML leukemogenesis (Figure 2) [37]. The gene discussed is KMT2A; the disease is acute myeloid leukemia.